Kyverna Therapeutics (KYTX) Capital Leases (2023 - 2025)

Kyverna Therapeutics (KYTX) posted Capital Leases of $8000.0 for Q3 2025, down 69.23% on a QoQ basis from $26000.0 in Q2 2025, and down 96.62% year-over-year from $237000.0 in Q3 2024.

Kyverna Therapeutics (KYTX) Capital Leases (2023 - 2025) Analysis & Trends

Kyverna Therapeutics' Capital Leases history runs 3 years deep, the most recent figure standing at $8000.0 for Q3 2025.

  • Quarterly Capital Leases fell 96.62% year-over-year to $8000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8000.0 (down 96.62% YoY) and the FY2024 annual result came in at $142000.0, down 84.58% from the prior year.
  • Capital Leases was $8000.0 for Q3 2025 at Kyverna Therapeutics, down from $26000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $921000.0 in Q4 2023 and bottomed at $8000.0 in Q3 2025.
  • A 3-year average of $310125.0 and a median of $189500.0 in 2024 frame the typical range for Capital Leases.
  • Annual changes were most pronounced in 2024 — Capital Leases tumbled 84.58% — and 2025, when it sank 96.62%.
  • Kyverna Therapeutics' Capital Leases stood at $921000.0 in 2023, then sank by 84.58% to $142000.0 in 2024, then sank by 94.37% to $8000.0 in 2025.
  • Business Quant data shows KYTX's Capital Leases at $8000.0 in Q3 2025, $26000.0 in Q2 2025, and $73000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Kyverna Therapeutics 447.52 Mn 447.52 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 8,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 73,000.00
Dec 31, 2024 142,000.00
Sep 30, 2024 237,000.00
Jun 30, 2024 407,000.00
Mar 31, 2024 667,000.00
Dec 31, 2023 921,000.00